Background Swaziland has the highest national HIV prevalence worldwide. The Swaziland HIV Incidence Measurement Survey (SHIMS) provides the fi rst national HIV incidence estimate based on prospectively observed HIV seroconversions.
Introduction
Swaziland has the most severe HIV epidemic in the world, with a measured HIV prevalence of 26% among adults aged 15-49 years in 2006-07. 1 To combat this epidemic, in 2009, the Government of the Kingdom of Swaziland (GKOS) initiated support for scale-up of national HIV prevention and treatment programmes, including a voluntary medical male circumcision campaign. 2 The Swaziland HIV Incidence Measurement Survey (SHIMS) was designed to assess the eff ect of these programmes on HIV incidence by prospectively measuring HIV seroconversions in a household-based, nationally representative sample of adults before and after programme expansion.
The approach of "know your epidemic, know your response" 3 is crucial to eff ective HIV programmes, and having accurate and detailed HIV incidence estimates is fundamental to this approach. Incidence estimates allow identifi cation of groups at the highest risk of new infections and, when repeated, determine the eff ect of programmes over time. Although incidence estimates of large populations are often modelled from trends in HIV prevalence, 4 such modelled estimates provide little demographic detail. HIV incidence laboratory assays 5, 6 are intended for use in cross-sectional surveys but have yet to achieve optimum performance. 7 HIV incidence estimates based on the gold standard of observed HIV seroconversions have not been available at a national level although they have been available from randomised clinical trials or observational cohorts restricted to subpopulations at increased risk of HIV. 8, 9 We report the national estimate, before programme expansion, of HIV incidence based on population-level, prospectively observed seroconversions.
Methods

Study design and participants
A two-stage sampling design was used to obtain a cross-sectional, nationally representative sample of adults aged 18-49 years in a survey of 14 891 households from 575 enumeration areas in Swaziland (fi gure 1), with household sample size calculations and other details as previously reported. 10 Each selected household was approached by study personnel trained in Good Clinical Practice 11 who asked responding heads of household to report the sex and age of all household members. All individuals aged 18-49 years who resided or had slept in the household the night before and were willing to undergo home-based HIV testing, answer demographic and behavioural questions in English or siSwati, and provide written informed consent were eligible for the study. We enrolled in the prospective HIV incidence cohort those HIV-seronegative individuals who consented to have a 6 month follow-up home-based HIV testing and counselling visit. The SHIMS protocol and consent forms were reviewed and approved by the GKOS Scientifi c and Ethics Committee and the institutional review boards at Columbia University Medical Center and the US Centers for Disease Control and Prevention.
Procedures
Study teams comprising one nurse and one or two counsellors did HIV counselling, venepuncture, and rapid HIV testing, provided condoms, and collected demographic, clinical, and behavioural information with questionnaires 12 administered during face-to-face interviews in a private location in or just outside the home. HIV test results were given to participants during the household visit. All HIV-seronegative individuals enrolled in the HIV incidence cohort had a 6 month follow-up visit, with similar procedures, including verifi cation of participant identity and repeat HIV testing. At the baseline and 6 month follow-up interviews, information was obtained about sexual behaviours in the past 6 months and characteristics of the three most
Research in context
Evidence before this study Swaziland's Demographic and Health Survey done in 2006-07 showed a severe generalised epidemic, with an HIV prevalence of 26% in 15-49 year olds. UNAIDS' modelled estimates of prevalence and incidence indicated a similarly severe epidemic. With a goal of reducing new HIV infections, Swaziland planned to scale up national treatment and prevention programmes. The Swaziland HIV Incidence Measurement Survey (SHIMS) was designed to assess HIV incidence before and after scale-up of these intervention programmes by measuring prospectively observed HIV seroconversion in a nationally representative adult cohort. A search of PubMed for studies published in English through to Nov 7, 2016 , using the search terms "HIV incidence", "longitudinal cohort", and "nationally representative" confi rmed no previous direct measurement of national HIV incidence using this method.
Added value of this study
This study reports the baseline results, before scale up of national interventions, of the fi rst national HIV incidence measurement on the basis of prospectively observed seroconversion, the "gold standard" measure of the spread of infection. High retention rates, a rigorous HIV testing algorithm, and a large number of seroconverter cases permit an accurate and detailed description of HIV incidence in Swaziland, a country at the centre of the global HIV epidemic.
Implications of all the available evidence
As the global scale-up of antiretroviral treatment extends into its second decade, accurate and detailed knowledge of each country's epidemic is increasingly crucial to implement an eff ective local HIV response. publications/type/studyprotocol-case-review-forms recent sexual partners. Current pregnancy status in women was based on self-report. All individuals who tested HIV seropositive at either the baseline or follow-up visit were counselled and referred to HIV care as per national guidelines.
Rapid HIV testing was done in the fi eld on whole blood samples obtained by venepuncture, as previously described. 10, 13 Samples were initially tested with Determine HIV-1/2Ag/Ab Combo (Alere, Japan) and Determine-reactive samples were confi rmed with Uni-Gold HIV Test (Trinity Biotech, Ireland), following Swaziland's serial testing algorithm. All HIVseronegative samples from the baseline visit, but not the follow-up visit, had a nucleic acid amplifi cation test (NAAT) with pools of ten samples to identify individuals with virological evidence of acute HIV infection. 14, 15 Individuals with NAAT-positive results had follow-up visits within 6 months to confi rm seroconversion and were subsequently censored from the incidence analyses. 
Statistical analysis
Probability of household selection within census enumeration areas of each of the four regions was designed to be proportional to population size and all household members were approached for selection. Corresponding design weights were then adjusted for nonresponse, within cross classifi cation of age group, region, urban or rural living area, and sex, and post-stratifi cation weights were calculated to match these same characteristics of the 2007 Swaziland census. Weights were scaled so that the weighted total matched the unweighted total number of participants. Proportions and 95% CIs were computed with survey sampling methods, weighted for sampling design, 10, 16 non-response, and post-stratifi cation, to achieve nationally representative fi ndings.
Unless otherwise noted, all analyses were based on all those individuals who were enrolled in the incidence cohort and who completed a follow-up visit; similarly, unless otherwise indicated, for each variable, 1% of participants or less refused to answer the question, answered "I don't know", or had missing data, and these data were excluded. We used statistical methods for multistage surveys throughout, and all models were fi tted with SAS, version 9.2. We used survey Poisson regression models to estimate seroincidence rates and CIs.
We analysed factors associated with the risk of seroconversion with survey proportional hazards, including number of sexual partners, marital status, condom use, knowledge of partner's HIV status, pregnancy, and circumcision status. To avoid imposing an assumption of constant HIV risk, we used the Cox proportional hazards model, rather than the Poisson regression model, to assess associations of baseline covariates with HIV seroincidence.
We fi tted all regression models separately for men and women. Variables were included in the multi variable models when the covariate had a p value lower than 0•1 in the univariable model. For explanatory variables expected to be consistent over a 6 month period, such as age, marital status, and HIV testing history, the analyses used data collected at baseline; for variables of sexual history, sexual activity in the past 6 months, pregnancy, and male circumcision status, the analysis used data collected at baseline and follow-up. To estimate the risk of HIV seroconversion for covariates of sexual behaviour, such as number of partners in the past 6 months, the analysis used data reported at follow-up, during the period of risk of HIV seroconversion. Population attributable risk was computed with the adjusted hazard ratio (aHR) to estimate the relative risk.
Role of the funding source
The funder participated in study design, data analysis, data interpretation, and writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication. Among those who reported ever having had sex, most reported at the follow-up visit having one sexual partner within the past 6 months and 967 (10%) of 9855 participants: 874 (18%) of 4788 men and 93 (2%) of 5067 women reported having two or more partners in the past 6 months. Among individuals reporting one or more partners in the past 6 months, most reported all partners as HIV negative, 917 (12%) of 8048 reported one or more HIV-positive partner, and 920 (11%) of 8048 reported having any partner with unknown HIV status. Among individuals reporting one or more partners in the past 6 months, only 24 (<1%) of 8048 reported anal sex, and most opted not to answer this question (data not shown). Potentially eligible HIV-seronegative adults who did not participate in the incidence cohort were less likely to be married (p=0·003), more likely to have two or more partners (p=0·002), and were less likely to have previously tested for HIV (p=0·015).
After applying survey weighting, 145 HIV sero conversions occurred during 6086 person-years of observation, corresponding to an annualised population incidence estimate of 2 . Age, employment status, sexual activity in the past 6 months, number of partners in the past 6 months, partner's HIV status, and condom use were included in the multivariable model for the men, and partner's HIV status in the past 6 months emerged as the only signifi cant independent predictor of seroconversion for men (table 3) . In analyses adjusted for sexual activity, number of partners and condom use, all in the past 6 months, as well as age and employment, the risk of seroconversion was markedly higher in those men reporting a partner who was either HIV positive (HR 2·67, 95% CI 1·06-6·82) or of unknown HIV status (4·64, 2·32-9·7, p<0·0001), compared with reporting only HIV-negative partners. Reporting an HIV-positive partner accounted for 16% of HIV incidence in men and a partner of unknown status 30%, on the basis of the calculated population attributable risk (data not shown). Data are survey weighted. Numbers might not add to 100% because of rounding. *Indicates data were collected at baseline visit. †Education refers to highest level of education ever attended, whether or not that level was completed. ‡Indicates that data were collected at follow-up visit; unless otherwise indicated, for each variable, 1% or fewer participants refused to answer the question, answered "I don't know", or had missing data (in these cases data were excluded for the variable). ¶The variables "lifetime sexual activity" and "recent sexual activity" were constructed from responses to questions at both baseline and follow-up. There were 113 people who responded that they had "never had sex" at follow-up but had indicated at the baseline visit that they had been sexually active. These individuals were assigned to the category "sexual activity reported at baseline only" within the "recent sexual activity" variable. Among women reporting sexual risk behaviours or partner characteristics associated with risk, incidence was increased: for example, two or more sexual partners in the past 6 months (HIV incidence was 10 Reporting any partner with unknown HIV status accounted for 16% of HIV incidence (data not shown).
Discussion
The national HIV incidence estimate from SHIMS, a prospective survey of adults in Swaziland, on the basis of observed seroconversions was 2•4% in 2011. Modelled estimates of HIV seroincidence have ranked Swaziland's HIV incidence as the highest globally for more than a decade, at 4•07% in 2001 and 2•66% in 2009. 17, 18 Taking into account important diff erences in methods, the 2011 SHIMS estimate is consistent with previous modelled estimates, confi rming that HIV incidence in Swaziland is alarmingly high but might be stable. Key subsets of the population, including women aged 20-24 years and 35-39 years and men aged 30-34 years, had incidence rates substantially higher than the national rate.
Few characteristics were independent predictors of HIV seroconversion in our study, emphasising the homogeneous nature of this generalised epidemic. For women, reporting no sexual activity at baseline or follow-up was protective, as might be expected; this Unless otherwise indicated for each variable, 1% or fewer participants refused to answer the question, answered "I don't know", or had missing data; these data were excluded for the variable. *Incidence estimates are based on weighted number of seroconversions. †Measured at baseline. ‡Measured at follow-up visit. predictor, however, had only marginal statistical signifi cance. For both women and men, a signifi cant predictor of HIV acquisition was reporting a sex partner with unknown HIV status in the past 6 months. Although most (89%) of the sexually active, seronegative population of adults in Swaziland reported knowing the HIV status of partners they have been with in the past 6 months, only 65% of seronegative adults and 71% of the overall adult population in Swaziland 10 reported any HIV testing before participation in SHIMS. This discrepancy between knowledge of partner's status and the prevalence of reporting prior testing suggests it will be crucial to expand HIV testing through a wide range of approaches while encouraging HIV disclosure to partners. 19 The high population attributable risk observed with reporting partners in the past 6 months with unknown HIV status, and for women, being unmarried, also suggests the need to consider the use of pre-exposure prophylaxis, 20 expansion of voluntary medical male circumcision, and continued scale-up of treatment as prevention, with use of antiretroviral therapy at higher CD4 thresholds. [21] [22] [23] Key strengths of this study included the systematic sampling of a household-based population, a high rate of participation in those sampled, and a high cohort retention rate. Although the study did not directly assess the role of migration and migrant labour on the epidemic, transient individuals who spent the previous night in someone's home were included in the sampled population. Additionally, having a partner who lives elsewhere, a characteristic which might indicate a partner involved in migrant labour, accounted for 25% of the HIV incidence in women. A rigorous HIV testing algorithm excluded seronegative individuals with acute HIV detected by NAAT testing at enrolment and determined the primary endpoint of HIV seroconversion.
The number of seroconverters permitted detailed assessment of predictors of HIV acquisition. Moreover, Swaziland's geographic location near other high prevalence countries in southern Africa make the results of this study highly relevant to the southern Africa region, the centre of the global HIV epidemic.
Study limitations include some imbalance in survey participation, with fewer men and fewer younger individuals taking part. The sex bias refl ects the greater number of women than men in the overall Swaziland population (53% vs 47% 1 ) and higher participation rates by women than men in the SHIMS household survey (81% vs 64% 10 ). These sex and age biases, however, were reduced by the weighting of the data. Because we did not include injection drug use and men who have sex with men behaviours in the model, we were unable to quantify the attributable risk of these well known risk behaviours. The survey did not collect data for injection drug behaviours, but did collect data on anal sex; however, the non-response rate for this question was too high to permit inclusion in the proportional hazards model. The survey also collected data about the number of partners in the past 6 months, a behaviour associated with sex work; this variable was included in the model but was not a signifi cant predictor. Because institutionalised individuals whose HIV incidence might be higher or lower than found in SHIMS were not included, the SHIMS estimates of HIV incidence might underrepresent or over-represent actual HIV incidence.
HIV incidence was defi ned solely by seroconversion and NAAT testing was not conducted at follow-up; this approach might have led to a potential underestimate of overall incidence of almost 9% (ie, 2·4% vs 2·6%), assuming a similar number of acute cases at enrolment and follow-up. The study was not powered to determine independent predictors of HIV seroconversion, and this might explain why some factors previously linked with HIV protection or acquisition were not signifi cant predictors of HIV acquisition, such as age in women and circumcision in men. Finally, although this was an observational study, risk-reduction counselling and the provision of condoms during the enrolment phase might have altered participants' risk behaviours and reduced the observed incidence rates below that of the rest of the national population. SHIMS2, a cross-sectional, population-based HIV survey in Swaziland, has recently begun (Aug 30, 2016) and will assess the national estimate of HIV incidence after the 2009 programme expansion. As with other population-based HIV impact assessments, 24 the cross-sectional design of SHIMS2 will assess HIV incidence by taking advantage of advances in HIV incidence assays, namely the limiting antigen avidity assay combined with HIV RNA (viral load) 7 rather than prospectively observed seroconversions. Results should be available by late 2017 and, when available, will show whether the epidemic in Swaziland has improved or is Sexual activity at follow-up only 0·7 (0·27-1·79) 0·98 (0·4-2·42) 0·97 1·59 (0·85-3·00) 1·39 (0·71-2·73) 0·34
Sexual activity not reported at baseline or at follow-up
Number of partners in the past 6 months (of those who ever had sex) † p=0·0043 p=0·48 ·· p=0·11 ·· ··
Condom use in the past 6 months † p=0·0060 p=0·17 ·· p=0·028 p=0·71 ··
HIV status of sexual partners in the past 6 months (in those with one or more partners in the past 6 months) † Univariable and multivariable models were each analysed separately for men and for women and HR and aHR from the multivariable models are shown. Those characteristics that were signifi cant at or near p<0·10 in the univariable model were included in each multivariable model. Not shown are those characteristics for which p was greater than 0·10 in the univariable models for men and for women: region, geography (urban vs rural), and HIV testing history (any vs never) for men and for women; circumcision status for men; and pregnancy status for women. HR=hazard ratio. aHR=adjusted hazard ratio. *Measured at baseline visit. †Measured at follow-up visit. much the same. SHIMS2 and population-based HIV impact assessments will allow us to understand whether incidence remains the most suitable measure of a national HIV epidemic or whether other indicators, such as viral load suppression, will emerge as a more informative indicator. Overall, this study is the fi rst to report HIV incidence at a national level with the use of prospectively observed HIV seroconversion. The national HIV incidence in Swaziland of 2•4% is the highest national rate known. We found alarmingly high rates in men and women in specifi c age strata. In the context of Swaziland's treatment and male circumcision coverage, these high incidence rates warrant further expansion of treatment initiation criteria and male circumcision scale-up in Swaziland. Our fi ndings show the value of detailed incidence measures in characterising those at highest risk of new infections and emphasise the need in high-prevalence countries for evidence-based HIV programmes that include frequent HIV testing, support for disclosure of HIV status, expansion of HIV treatment, and consideration of pre-exposure prophylaxis as public health priorities.
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